Patient outcome

Age (Yr)FemaleVAS Pre-AblationVAS Post-AblationVAS Reductiona
Mean7764%8.21.977%
SD7.81.71.6
  • ↵a Statistically significant reduction in mean VAS as determined by the Wilcoxon signed-rank test (P < .05).